Assignee
GRITSTONE ONCOLOGY INC
US·3 granted patents·10 pending applications·21 citations·filing 2016–2019
Top patents by PatentIndex Score
13 records- 0191US10055540B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2017·Granted Aug 21, 2018·21 cites·25 claims
- 0266US10847253B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·30 claims
- 0365US10847252B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·31 claims
- 0460US2019034585A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 0556US2021213122A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 0655US2017199961A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2016·Application pending·0 cites
- 0754US2021113673A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 0848US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 0947US2021196806A1Shared antigensGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1042US2020411135A1Neoantigen Identification with Pan-Allele ModelsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1140US2020105377A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1238US2021061914A1Antigen-Binding Proteins Targeting Shared AntigensGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1333US2020363414A1Neoantigen Identification for T-Cell TherapyGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GRITSTONE ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →